Want to see HK:1830 full AI Analyst Report?
Perfect Medical Health Management Limited (1830) Ratios
11 Followers
Perfect Medical Health Management Limited Ratios
HK:1830's free cash flow for Q4 2025 was HK$153.04M. For the 2025 fiscal year, HK:1830's free cash flow was decreased by HK$-30.26M and operating cash flow was HK$183.29M. See a summary of the company’s cash flow.
| Ratios | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.06 | 1.18 | 1.35 | 1.44 | 0.97 |
| Quick Ratio | 1.04 | 1.15 | 1.34 | 1.44 | 0.96 |
| Cash Ratio | 0.44 | 0.62 | 1.10 | 0.86 | 0.87 |
| Solvency Ratio | 0.74 | 0.69 | 0.71 | 0.79 | 0.67 |
| Operating Cash Flow Ratio | 1.01 | 0.83 | 0.96 | 1.08 | 0.99 |
| Short-Term Operating Cash Flow Coverage | 5.82 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | HK$ -90.61M | HK$ -85.57M | HK$ -27.86M | HK$ 68.27M | HK$ -278.84M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.16 | 0.23 | 0.22 | 0.19 | 0.24 |
| Debt-to-Equity Ratio | 0.35 | 0.57 | 0.54 | 0.39 | 0.63 |
| Debt-to-Capital Ratio | 0.26 | 0.36 | 0.35 | 0.28 | 0.39 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 2.15 | 2.46 | 2.46 | 2.12 | 2.59 |
| Debt Service Coverage Ratio | 5.08 | 35.73 | 46.65 | 41.25 | 32.92 |
| Interest Coverage Ratio | 27.21 | 22.71 | 34.07 | 29.45 | 23.84 |
| Debt to Market Cap | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.11 | 0.18 | 0.22 | 0.20 | 0.27 |
| Net Debt to EBITDA | -0.03 | -0.07 | -0.50 | -0.35 | -0.24 |
| Profitability Margins | |||||
| Gross Profit Margin | 47.22% | 63.77% | 65.41% | 47.69% | 51.11% |
| EBIT Margin | 22.48% | 23.37% | 28.35% | 26.55% | 28.43% |
| EBITDA Margin | 38.40% | 39.19% | 42.84% | 42.64% | 44.66% |
| Operating Profit Margin | 22.48% | 22.31% | 27.44% | 26.55% | 28.43% |
| Pretax Profit Margin | 21.94% | 22.39% | 27.54% | 28.18% | 28.01% |
| Net Profit Margin | 18.57% | 18.34% | 22.66% | 22.72% | 22.61% |
| Continuous Operations Profit Margin | 18.53% | 18.30% | 22.28% | 22.72% | 22.61% |
| Net Income Per EBT | 84.63% | 81.92% | 82.30% | 80.63% | 80.72% |
| EBT Per EBIT | 97.64% | 100.36% | 100.35% | 106.14% | 98.53% |
| Return on Assets (ROA) | 21.42% | 22.11% | 25.85% | 24.35% | 23.82% |
| Return on Equity (ROE) | 46.08% | 54.45% | 63.48% | 51.55% | 61.76% |
| Return on Capital Employed (ROCE) | 43.38% | 46.89% | 54.24% | 47.56% | 50.61% |
| Return on Invested Capital (ROIC) | 32.80% | 32.28% | 38.57% | 33.41% | 34.67% |
| Return on Tangible Assets | 21.42% | 22.11% | 25.85% | 24.35% | 23.82% |
| Earnings Yield | 12.70% | 7.26% | 8.03% | 6.40% | 5.11% |
| Efficiency Ratios | |||||
| Receivables Turnover | 29.84 | 35.41 | 22.01 | 27.60 | 84.44 |
| Payables Turnover | 215.21 | 474.62 | 450.44 | 867.14 | 414.60 |
| Inventory Turnover | 96.96 | 29.27 | 74.78 | 0.00 | 112.41 |
| Fixed Asset Turnover | 4.75 | 3.56 | 3.38 | 3.39 | 2.44 |
| Asset Turnover | 1.15 | 1.21 | 1.14 | 1.07 | 1.05 |
| Working Capital Turnover Ratio | 20.82 | 8.93 | 6.77 | 12.82 | 33.95 |
| Cash Conversion Cycle | 14.30 | 22.01 | 20.65 | 12.80 | 6.69 |
| Days of Sales Outstanding | 12.23 | 10.31 | 16.58 | 13.22 | 4.32 |
| Days of Inventory Outstanding | 3.76 | 12.47 | 4.88 | 0.00 | 3.25 |
| Days of Payables Outstanding | 1.70 | 0.77 | 0.81 | 0.42 | 0.88 |
| Operating Cycle | 16.00 | 22.78 | 21.46 | 13.22 | 7.57 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.27 | 0.26 | 0.40 | 0.45 | 0.42 |
| Free Cash Flow Per Share | 0.25 | 0.24 | 0.35 | 0.43 | 0.30 |
| Dividend Paid and CapEx Coverage Ratio | 1.77 | 0.85 | 1.11 | 2.57 | 0.94 |
| Capital Expenditure Coverage Ratio | 11.22 | 9.61 | 9.18 | 20.96 | 3.57 |
| Operating Cash Flow Coverage Ratio | 2.52 | 1.54 | 1.85 | 2.33 | 1.66 |
| Operating Cash Flow to Sales Ratio | 0.35 | 0.30 | 0.36 | 0.40 | 0.38 |
| Free Cash Flow Yield | 21.98% | 10.46% | 11.33% | 10.82% | 6.24% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 8.00 | 14.19 | 12.45 | 15.63 | 19.55 |
| Price-to-Sales (P/S) Ratio | 1.46 | 2.53 | 2.82 | 3.55 | 4.42 |
| Price-to-Book (P/B) Ratio | 3.63 | 7.51 | 7.90 | 8.06 | 12.08 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 4.55 | 9.56 | 8.83 | 9.24 | 16.04 |
| Price-to-Operating Cash Flow Ratio | 4.14 | 8.57 | 7.91 | 8.80 | 11.55 |
| Price-to-Earnings Growth (PEG) Ratio | -0.64 | -0.39 | 0.00 | 0.00 | 4.69 |
| Enterprise Value Multiple | 3.77 | 6.38 | 6.09 | 7.98 | 9.66 |
| Enterprise Value | 1.39B | 2.82B | 3.63B | 4.73B | 5.83B |
| EV to EBITDA | 3.77 | 6.38 | 6.09 | 7.98 | 9.66 |
| EV to Sales | 1.45 | 2.50 | 2.61 | 3.40 | 4.32 |
| EV to Free Cash Flow | 4.51 | 9.45 | 8.16 | 8.86 | 15.65 |
| EV to Operating Cash Flow | 4.11 | 8.47 | 7.31 | 8.43 | 11.27 |
| Tangible Book Value Per Share | 0.31 | 0.30 | 0.40 | 0.49 | 0.40 |
| Shareholders’ Equity Per Share | 0.31 | 0.30 | 0.40 | 0.49 | 0.40 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.16 | 0.18 | 0.19 | 0.19 | 0.19 |
| Revenue Per Share | 0.77 | 0.90 | 1.11 | 1.11 | 1.10 |
| Net Income Per Share | 0.14 | 0.16 | 0.25 | 0.25 | 0.25 |
| Tax Burden | 0.85 | 0.82 | 0.82 | 0.81 | 0.81 |
| Interest Burden | 0.98 | 0.96 | 0.97 | 1.06 | 0.99 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.25 | 0.14 | 0.02 | 0.02 | 0.01 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.61 | 1.32 | 1.57 | 1.78 | 1.69 |
Currency in HKD
